ZYDUSWELL · Concall Summary
ZYDUS WELLNESS LIMITED
During the Q1 FY27 earnings conference call held on August 4, 2026, management reported that consumer demand remained resilient, with a notable shift towards higher value products. The company experienced a consolidated net sales growth of 66.7% year-on-year, reaching INR 14,299 million. The international business grew by 24.8%, while the domestic business saw a 4.6% increase. Management noted that seasonal demand was affected by unseasonal rainfall, particularly impacting brands like Nycil. Despite this, key brands showed strong double-digit growth. The EBITDA grew by 55.3%, reaching INR 2,417 million, although net profit declined by 7%. Management highlighted ongoing innovation, including new product launches in the Complan and Comfort Click segments, and emphasized a long-term strategy focused on premium offerings and technology-driven decision-making.
Management highlighted both growth opportunities and challenges faced during the quarter.
View source filing →Earlier concalls
- 2026-08-04 — The investor presentation from Zydus Wellness Limited, dated August 4, 2026, outlines the company's unaudited financial …
- 2026-05-22 — During the Q4 FY2026 earnings conference call, management reported a steady recovery in rural demand, which outpaced urb…
- 2026-05-18 — The investor presentation from Zydus Wellness Limited, dated May 18, 2026, outlines the company's audited financial resu…
See ZYDUSWELL's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free